All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study finds persistently high mortality in drug-resistant Gram-negative infections despite new antibiotics

By

Sameer S Kadri, MDa,b,c Send email to [email protected]

9d ago· 33 min readenInsight

Summary

This retrospective cohort study examines whether mortality rates among patients with difficult-to-treat resistant (DTR) Gram-negative infections have changed since the introduction of newer, next-generation antibiotics in the USA. Despite the availability of these improved antibiotics, the study finds that mortality and the use of in-vitro discordant initial antibiotics remain unacceptably high. The research highlights that prompt recognition of both the pathogen and resistance phenotype is crucial for reducing mortality. A notable decrease in adjusted mortality over time was observed for Pseudomonas aeruginosa bloodstream infections, though this finding is considered hypothesis-generating due to the small cohort size.

Source

bskyStudy finds persistently high mortality in drug-resistant Gram-negative infections despite new antibioticsthelancet.com

Key quotes

· 3 pulled
Despite the availability of newer antibiotic agents, the estimated mortality and ongoing use of in-vitro discordant initial antibiotics remains unacceptably high among patients with DTR infections in US hospitals.
Prompt recognition of both the pathogen and resistance phenotype could be a crucial component in reducing mortality.
Although notable, the decrease over time in adjusted mortality for P aeruginosa bloodstream infections should be considered hypothesis-generating because the cohort of patients with such infections was small.
Snippet from the RSS feed
Despite the availability of newer antibiotic agents, the estimated mortality and ongoing use of in-vitro discordant initial antibiotics remains unacceptably high among patients with DTR infections in US hospitals. Prompt recognition of both the pathogen a

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.